Diabetic Macular Edema (DME) Active Not Recruiting Phase 2 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05151744A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular EdemaTreatment
NCT05151731A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular EdemaTreatment